These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14678966)

  • 21. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein.
    Brummer T; Martin P; Herzog S; Misawa Y; Daly RJ; Reth M
    Oncogene; 2006 Oct; 25(47):6262-76. PubMed ID: 16702958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase.
    Hatakeyama M; Yumoto N; Yu X; Shirouzu M; Yokoyama S; Konagaya A
    Oncogene; 2004 Jun; 23(29):5023-31. PubMed ID: 15064721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
    Vial E; Marshall CJ
    J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of NF-kappa B by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade.
    Troppmair J; Hartkamp J; Rapp UR
    Oncogene; 1998 Aug; 17(6):685-90. PubMed ID: 9715269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
    Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
    Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
    Wan PT; Garnett MJ; Roe SM; Lee S; Niculescu-Duvaz D; Good VM; Jones CM; Marshall CJ; Springer CJ; Barford D; Marais R;
    Cell; 2004 Mar; 116(6):855-67. PubMed ID: 15035987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
    Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
    Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-raf and Ha-ras mutations in chemically induced mouse liver tumors.
    Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M
    Oncogene; 2005 Feb; 24(7):1290-5. PubMed ID: 15592514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.
    Dhillon AS; Meikle S; Peyssonnaux C; Grindlay J; Kaiser C; Steen H; Shaw PE; Mischak H; Eychène A; Kolch W
    Mol Cell Biol; 2003 Mar; 23(6):1983-93. PubMed ID: 12612072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
    Anders M; Christian C; McMahon M; McCormick F; Korn WM
    Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.
    Sobczak I; Galabova-Kovacs G; Sadzak I; Kren A; Christofori G; Baccarini M
    Oncogene; 2008 Aug; 27(35):4779-87. PubMed ID: 18490924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
    Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
    Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of PIK3CA gene mutations in human colorectal cancer.
    Ikenoue T; Kanai F; Hikiba Y; Obata T; Tanaka Y; Imamura J; Ohta M; Jazag A; Guleng B; Tateishi K; Asaoka Y; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2005 Jun; 65(11):4562-7. PubMed ID: 15930273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome.
    Deichmann M; Thome M; Benner A; Näher H
    Oncology; 2004; 66(5):411-9. PubMed ID: 15331929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of the BRAF gene in human cancer.
    Davies H; Bignell GR; Cox C; Stephens P; Edkins S; Clegg S; Teague J; Woffendin H; Garnett MJ; Bottomley W; Davis N; Dicks E; Ewing R; Floyd Y; Gray K; Hall S; Hawes R; Hughes J; Kosmidou V; Menzies A; Mould C; Parker A; Stevens C; Watt S; Hooper S; Wilson R; Jayatilake H; Gusterson BA; Cooper C; Shipley J; Hargrave D; Pritchard-Jones K; Maitland N; Chenevix-Trench G; Riggins GJ; Bigner DD; Palmieri G; Cossu A; Flanagan A; Nicholson A; Ho JW; Leung SY; Yuen ST; Weber BL; Seigler HF; Darrow TL; Paterson H; Marais R; Marshall CJ; Wooster R; Stratton MR; Futreal PA
    Nature; 2002 Jun; 417(6892):949-54. PubMed ID: 12068308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.
    Dwivedi Y; Rizavi HS; Conley RR; Pandey GN
    Mol Psychiatry; 2006 Jan; 11(1):86-98. PubMed ID: 16172610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raf proteins and cancer: B-Raf is identified as a mutational target.
    Mercer KE; Pritchard CA
    Biochim Biophys Acta; 2003 Jun; 1653(1):25-40. PubMed ID: 12781369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.